nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—Progesterone—uterine cancer	0.376	1	CbGbCtD
Dicyclomine—CHRM3—ureter—uterine cancer	0.0606	0.366	CbGeAlD
Dicyclomine—CHRM3—muscle of abdomen—uterine cancer	0.0436	0.264	CbGeAlD
Dicyclomine—CHRM3—exocrine gland—uterine cancer	0.0119	0.0722	CbGeAlD
Dicyclomine—CHRM3—smooth muscle tissue—uterine cancer	0.005	0.0303	CbGeAlD
Dicyclomine—CHRM3—renal system—uterine cancer	0.00482	0.0291	CbGeAlD
Dicyclomine—CHRM1—female reproductive system—uterine cancer	0.00431	0.0261	CbGeAlD
Dicyclomine—CYP1A1—epithelium—uterine cancer	0.00389	0.0235	CbGeAlD
Dicyclomine—CHRM3—female reproductive system—uterine cancer	0.00386	0.0233	CbGeAlD
Dicyclomine—CYP1A1—uterine cervix—uterine cancer	0.00386	0.0233	CbGeAlD
Dicyclomine—CYP1A1—renal system—uterine cancer	0.00361	0.0218	CbGeAlD
Dicyclomine—CHRM3—female gonad—uterine cancer	0.00351	0.0212	CbGeAlD
Dicyclomine—CYP1A1—mammalian vulva—uterine cancer	0.00337	0.0204	CbGeAlD
Dicyclomine—CYP1A1—uterus—uterine cancer	0.00321	0.0194	CbGeAlD
Dicyclomine—CYP1A1—female reproductive system—uterine cancer	0.00289	0.0175	CbGeAlD
Dicyclomine—CYP1A1—female gonad—uterine cancer	0.00263	0.0159	CbGeAlD
Dicyclomine—CYP1A1—vagina—uterine cancer	0.00261	0.0158	CbGeAlD
Dicyclomine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00405	CcSEcCtD
Dicyclomine—Necrosis—Epirubicin—uterine cancer	0.00185	0.00403	CcSEcCtD
Dicyclomine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00402	CcSEcCtD
Dicyclomine—Dry mouth—Progesterone—uterine cancer	0.00184	0.00401	CcSEcCtD
Dicyclomine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00399	CcSEcCtD
Dicyclomine—Confusional state—Progesterone—uterine cancer	0.00182	0.00397	CcSEcCtD
Dicyclomine—Dermatitis atopic—Doxorubicin—uterine cancer	0.00181	0.00395	CcSEcCtD
Dicyclomine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00394	CcSEcCtD
Dicyclomine—Anaphylactic shock—Progesterone—uterine cancer	0.0018	0.00394	CcSEcCtD
Dicyclomine—Oedema—Progesterone—uterine cancer	0.0018	0.00394	CcSEcCtD
Dicyclomine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00392	CcSEcCtD
Dicyclomine—Ageusia—Epirubicin—uterine cancer	0.00179	0.0039	CcSEcCtD
Dicyclomine—Shock—Progesterone—uterine cancer	0.00177	0.00387	CcSEcCtD
Dicyclomine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00386	CcSEcCtD
Dicyclomine—Nervous system disorder—Progesterone—uterine cancer	0.00177	0.00386	CcSEcCtD
Dicyclomine—Tachycardia—Progesterone—uterine cancer	0.00176	0.00384	CcSEcCtD
Dicyclomine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00384	CcSEcCtD
Dicyclomine—Anorexia—Progesterone—uterine cancer	0.00172	0.00375	CcSEcCtD
Dicyclomine—Necrosis—Doxorubicin—uterine cancer	0.00171	0.00373	CcSEcCtD
Dicyclomine—CYP1A1—lymph node—uterine cancer	0.00169	0.0102	CbGeAlD
Dicyclomine—Delirium—Epirubicin—uterine cancer	0.00169	0.00368	CcSEcCtD
Dicyclomine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00368	CcSEcCtD
Dicyclomine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00364	CcSEcCtD
Dicyclomine—Ageusia—Doxorubicin—uterine cancer	0.00166	0.00361	CcSEcCtD
Dicyclomine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.0036	CcSEcCtD
Dicyclomine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00357	CcSEcCtD
Dicyclomine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00357	CcSEcCtD
Dicyclomine—Insomnia—Progesterone—uterine cancer	0.00163	0.00356	CcSEcCtD
Dicyclomine—Paraesthesia—Progesterone—uterine cancer	0.00162	0.00353	CcSEcCtD
Dicyclomine—Dyspnoea—Progesterone—uterine cancer	0.00161	0.00351	CcSEcCtD
Dicyclomine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00351	CcSEcCtD
Dicyclomine—Somnolence—Progesterone—uterine cancer	0.0016	0.0035	CcSEcCtD
Dicyclomine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0035	CcSEcCtD
Dicyclomine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00348	CcSEcCtD
Dicyclomine—Dyspepsia—Progesterone—uterine cancer	0.00159	0.00346	CcSEcCtD
Dicyclomine—Decreased appetite—Progesterone—uterine cancer	0.00157	0.00342	CcSEcCtD
Dicyclomine—Erythema—Dactinomycin—uterine cancer	0.00156	0.00341	CcSEcCtD
Dicyclomine—Delirium—Doxorubicin—uterine cancer	0.00156	0.0034	CcSEcCtD
Dicyclomine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.0034	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00156	0.0034	CcSEcCtD
Dicyclomine—Fatigue—Progesterone—uterine cancer	0.00155	0.00339	CcSEcCtD
Dicyclomine—Dyskinesia—Epirubicin—uterine cancer	0.00154	0.00337	CcSEcCtD
Dicyclomine—Constipation—Progesterone—uterine cancer	0.00154	0.00337	CcSEcCtD
Dicyclomine—Pain—Progesterone—uterine cancer	0.00154	0.00337	CcSEcCtD
Dicyclomine—Feeling abnormal—Progesterone—uterine cancer	0.00149	0.00324	CcSEcCtD
Dicyclomine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00323	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Progesterone—uterine cancer	0.00147	0.00322	CcSEcCtD
Dicyclomine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0032	CcSEcCtD
Dicyclomine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00318	CcSEcCtD
Dicyclomine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00317	CcSEcCtD
Dicyclomine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00145	0.00316	CcSEcCtD
Dicyclomine—Injection site reaction—Epirubicin—uterine cancer	0.00144	0.00314	CcSEcCtD
Dicyclomine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00314	CcSEcCtD
Dicyclomine—Urticaria—Progesterone—uterine cancer	0.00143	0.00313	CcSEcCtD
Dicyclomine—Dyskinesia—Doxorubicin—uterine cancer	0.00143	0.00311	CcSEcCtD
Dicyclomine—Abdominal pain—Progesterone—uterine cancer	0.00143	0.00311	CcSEcCtD
Dicyclomine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0031	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00308	CcSEcCtD
Dicyclomine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00307	CcSEcCtD
Dicyclomine—Malaise—Dactinomycin—uterine cancer	0.00141	0.00307	CcSEcCtD
Dicyclomine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00305	CcSEcCtD
Dicyclomine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00294	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00292	CcSEcCtD
Dicyclomine—Injection site reaction—Doxorubicin—uterine cancer	0.00133	0.00291	CcSEcCtD
Dicyclomine—Hypersensitivity—Progesterone—uterine cancer	0.00133	0.0029	CcSEcCtD
Dicyclomine—Discomfort—Dactinomycin—uterine cancer	0.00131	0.00287	CcSEcCtD
Dicyclomine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00283	CcSEcCtD
Dicyclomine—Asthenia—Progesterone—uterine cancer	0.00129	0.00282	CcSEcCtD
Dicyclomine—Hypoaesthesia—Etoposide—uterine cancer	0.00129	0.00282	CcSEcCtD
Dicyclomine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00282	CcSEcCtD
Dicyclomine—Pruritus—Progesterone—uterine cancer	0.00128	0.00278	CcSEcCtD
Dicyclomine—Oedema—Dactinomycin—uterine cancer	0.00127	0.00278	CcSEcCtD
Dicyclomine—Thrombophlebitis—Epirubicin—uterine cancer	0.00122	0.00265	CcSEcCtD
Dicyclomine—Anorexia—Dactinomycin—uterine cancer	0.00122	0.00265	CcSEcCtD
Dicyclomine—Eye disorder—Etoposide—uterine cancer	0.00121	0.00265	CcSEcCtD
Dicyclomine—Cardiac disorder—Etoposide—uterine cancer	0.00121	0.00263	CcSEcCtD
Dicyclomine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00263	CcSEcCtD
Dicyclomine—Dizziness—Progesterone—uterine cancer	0.00119	0.0026	CcSEcCtD
Dicyclomine—Immune system disorder—Etoposide—uterine cancer	0.00117	0.00256	CcSEcCtD
Dicyclomine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00256	CcSEcCtD
Dicyclomine—Mediastinal disorder—Etoposide—uterine cancer	0.00117	0.00255	CcSEcCtD
Dicyclomine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00252	CcSEcCtD
Dicyclomine—Vomiting—Progesterone—uterine cancer	0.00115	0.0025	CcSEcCtD
Dicyclomine—Rash—Progesterone—uterine cancer	0.00114	0.00248	CcSEcCtD
Dicyclomine—Dermatitis—Progesterone—uterine cancer	0.00114	0.00248	CcSEcCtD
Dicyclomine—Headache—Progesterone—uterine cancer	0.00113	0.00247	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—uterine cancer	0.00112	0.00245	CcSEcCtD
Dicyclomine—Decreased appetite—Dactinomycin—uterine cancer	0.00111	0.00242	CcSEcCtD
Dicyclomine—Fatigue—Dactinomycin—uterine cancer	0.0011	0.0024	CcSEcCtD
Dicyclomine—Pain—Dactinomycin—uterine cancer	0.00109	0.00238	CcSEcCtD
Dicyclomine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00236	CcSEcCtD
Dicyclomine—Lethargy—Epirubicin—uterine cancer	0.00107	0.00234	CcSEcCtD
Dicyclomine—Nausea—Progesterone—uterine cancer	0.00107	0.00234	CcSEcCtD
Dicyclomine—Diplopia—Epirubicin—uterine cancer	0.00105	0.0023	CcSEcCtD
Dicyclomine—Feeling abnormal—Dactinomycin—uterine cancer	0.00105	0.00229	CcSEcCtD
Dicyclomine—Ill-defined disorder—Etoposide—uterine cancer	0.00105	0.00229	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00104	0.00227	CcSEcCtD
Dicyclomine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00227	CcSEcCtD
Dicyclomine—Affect lability—Epirubicin—uterine cancer	0.00104	0.00226	CcSEcCtD
Dicyclomine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00225	CcSEcCtD
Dicyclomine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00225	CcSEcCtD
Dicyclomine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00223	CcSEcCtD
Dicyclomine—Malaise—Etoposide—uterine cancer	0.00102	0.00222	CcSEcCtD
Dicyclomine—Face oedema—Epirubicin—uterine cancer	0.00102	0.00222	CcSEcCtD
Dicyclomine—Abdominal pain—Dactinomycin—uterine cancer	0.00101	0.0022	CcSEcCtD
Dicyclomine—Mood swings—Epirubicin—uterine cancer	0.000997	0.00218	CcSEcCtD
Dicyclomine—Loss of consciousness—Etoposide—uterine cancer	0.000994	0.00217	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—uterine cancer	0.000993	0.00217	CcSEcCtD
Dicyclomine—Hypertension—Etoposide—uterine cancer	0.000976	0.00213	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—uterine cancer	0.000974	0.00212	CcSEcCtD
Dicyclomine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000971	0.00212	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—uterine cancer	0.000958	0.00209	CcSEcCtD
Dicyclomine—Discomfort—Etoposide—uterine cancer	0.000951	0.00207	CcSEcCtD
Dicyclomine—Breast disorder—Epirubicin—uterine cancer	0.000951	0.00207	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—uterine cancer	0.00094	0.00205	CcSEcCtD
Dicyclomine—Hypersensitivity—Dactinomycin—uterine cancer	0.000939	0.00205	CcSEcCtD
Dicyclomine—Confusional state—Etoposide—uterine cancer	0.00093	0.00203	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—uterine cancer	0.000928	0.00202	CcSEcCtD
Dicyclomine—Anaphylactic shock—Etoposide—uterine cancer	0.000923	0.00201	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—uterine cancer	0.000922	0.00201	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—uterine cancer	0.000915	0.002	CcSEcCtD
Dicyclomine—Asthenia—Dactinomycin—uterine cancer	0.000915	0.002	CcSEcCtD
Dicyclomine—Tachycardia—Etoposide—uterine cancer	0.0009	0.00196	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—uterine cancer	0.00088	0.00192	CcSEcCtD
Dicyclomine—Anorexia—Etoposide—uterine cancer	0.000879	0.00192	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—uterine cancer	0.000859	0.00187	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—uterine cancer	0.000847	0.00185	CcSEcCtD
Dicyclomine—Paraesthesia—Etoposide—uterine cancer	0.000828	0.00181	CcSEcCtD
Dicyclomine—Dyspnoea—Etoposide—uterine cancer	0.000822	0.00179	CcSEcCtD
Dicyclomine—Somnolence—Etoposide—uterine cancer	0.00082	0.00179	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—uterine cancer	0.000811	0.00177	CcSEcCtD
Dicyclomine—Vomiting—Dactinomycin—uterine cancer	0.00081	0.00177	CcSEcCtD
Dicyclomine—Rash—Dactinomycin—uterine cancer	0.000804	0.00175	CcSEcCtD
Dicyclomine—Decreased appetite—Etoposide—uterine cancer	0.000802	0.00175	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000796	0.00174	CcSEcCtD
Dicyclomine—Fatigue—Etoposide—uterine cancer	0.000795	0.00174	CcSEcCtD
Dicyclomine—Pain—Etoposide—uterine cancer	0.000789	0.00172	CcSEcCtD
Dicyclomine—Constipation—Etoposide—uterine cancer	0.000789	0.00172	CcSEcCtD
Dicyclomine—Feeling abnormal—Etoposide—uterine cancer	0.00076	0.00166	CcSEcCtD
Dicyclomine—Nausea—Dactinomycin—uterine cancer	0.000757	0.00165	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Etoposide—uterine cancer	0.000754	0.00165	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—uterine cancer	0.00075	0.00164	CcSEcCtD
Dicyclomine—Urticaria—Etoposide—uterine cancer	0.000733	0.0016	CcSEcCtD
Dicyclomine—Abdominal pain—Etoposide—uterine cancer	0.000729	0.00159	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—uterine cancer	0.000724	0.00158	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—uterine cancer	0.00068	0.00148	CcSEcCtD
Dicyclomine—Hypersensitivity—Etoposide—uterine cancer	0.00068	0.00148	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—uterine cancer	0.000676	0.00147	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—uterine cancer	0.00067	0.00146	CcSEcCtD
Dicyclomine—Asthenia—Etoposide—uterine cancer	0.000662	0.00144	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—uterine cancer	0.000657	0.00143	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—uterine cancer	0.000656	0.00143	CcSEcCtD
Dicyclomine—Pruritus—Etoposide—uterine cancer	0.000653	0.00142	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—uterine cancer	0.000638	0.00139	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—uterine cancer	0.000634	0.00138	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—uterine cancer	0.000629	0.00137	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—uterine cancer	0.000625	0.00136	CcSEcCtD
Dicyclomine—Tension—Epirubicin—uterine cancer	0.000622	0.00136	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—uterine cancer	0.000615	0.00134	CcSEcCtD
Dicyclomine—Dizziness—Etoposide—uterine cancer	0.00061	0.00133	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—uterine cancer	0.000608	0.00133	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000607	0.00132	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—uterine cancer	0.000597	0.0013	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—uterine cancer	0.00059	0.00129	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—uterine cancer	0.000588	0.00128	CcSEcCtD
Dicyclomine—Vomiting—Etoposide—uterine cancer	0.000587	0.00128	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—uterine cancer	0.000586	0.00128	CcSEcCtD
Dicyclomine—Agitation—Epirubicin—uterine cancer	0.000582	0.00127	CcSEcCtD
Dicyclomine—Rash—Etoposide—uterine cancer	0.000582	0.00127	CcSEcCtD
Dicyclomine—Dermatitis—Etoposide—uterine cancer	0.000581	0.00127	CcSEcCtD
Dicyclomine—Headache—Etoposide—uterine cancer	0.000578	0.00126	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—uterine cancer	0.000575	0.00126	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—uterine cancer	0.000571	0.00125	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—uterine cancer	0.000569	0.00124	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—uterine cancer	0.000568	0.00124	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—uterine cancer	0.00056	0.00122	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—uterine cancer	0.000557	0.00122	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—uterine cancer	0.000553	0.00121	CcSEcCtD
Dicyclomine—Nausea—Etoposide—uterine cancer	0.000548	0.0012	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—uterine cancer	0.000547	0.00119	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000544	0.00119	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—uterine cancer	0.000539	0.00118	CcSEcCtD
Dicyclomine—Discomfort—Epirubicin—uterine cancer	0.000533	0.00116	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—uterine cancer	0.000529	0.00115	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—uterine cancer	0.000528	0.00115	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—uterine cancer	0.000526	0.00115	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—uterine cancer	0.000521	0.00114	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—uterine cancer	0.000518	0.00113	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—uterine cancer	0.000517	0.00113	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—uterine cancer	0.000517	0.00113	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—uterine cancer	0.000515	0.00112	CcSEcCtD
Dicyclomine—Shock—Epirubicin—uterine cancer	0.000509	0.00111	CcSEcCtD
Dicyclomine—Nervous system disorder—Epirubicin—uterine cancer	0.000507	0.00111	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—uterine cancer	0.000506	0.0011	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—uterine cancer	0.000505	0.0011	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—uterine cancer	0.000493	0.00108	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—uterine cancer	0.000493	0.00108	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—uterine cancer	0.000488	0.00107	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—uterine cancer	0.000482	0.00105	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—uterine cancer	0.000478	0.00104	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000478	0.00104	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—uterine cancer	0.000471	0.00103	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—uterine cancer	0.000469	0.00102	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—uterine cancer	0.000468	0.00102	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—uterine cancer	0.000467	0.00102	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—uterine cancer	0.000464	0.00101	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—uterine cancer	0.000461	0.00101	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—uterine cancer	0.00046	0.001	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—uterine cancer	0.000456	0.000995	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—uterine cancer	0.000455	0.000993	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—uterine cancer	0.00045	0.000981	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000446	0.000974	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—uterine cancer	0.000446	0.000973	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—uterine cancer	0.000442	0.000965	CcSEcCtD
Dicyclomine—Pain—Epirubicin—uterine cancer	0.000442	0.000965	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—uterine cancer	0.000433	0.000944	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—uterine cancer	0.00043	0.000938	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—uterine cancer	0.000427	0.000931	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—uterine cancer	0.000426	0.00093	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—uterine cancer	0.000425	0.000928	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000423	0.000923	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—uterine cancer	0.000421	0.000919	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—uterine cancer	0.000416	0.000908	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000413	0.000901	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—uterine cancer	0.000413	0.0009	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—uterine cancer	0.000411	0.000896	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—uterine cancer	0.000409	0.000893	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—uterine cancer	0.000409	0.000893	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—uterine cancer	0.000409	0.000892	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—uterine cancer	0.000394	0.00086	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000391	0.000854	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—uterine cancer	0.000381	0.000831	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—uterine cancer	0.00038	0.000829	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—uterine cancer	0.000378	0.000825	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—uterine cancer	0.000371	0.00081	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—uterine cancer	0.000366	0.000798	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—uterine cancer	0.000353	0.000769	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—uterine cancer	0.000343	0.000749	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—uterine cancer	0.000342	0.000746	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—uterine cancer	0.000339	0.000739	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—uterine cancer	0.000329	0.000717	CcSEcCtD
Dicyclomine—Rash—Epirubicin—uterine cancer	0.000326	0.000712	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—uterine cancer	0.000326	0.000711	CcSEcCtD
Dicyclomine—Headache—Epirubicin—uterine cancer	0.000324	0.000707	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—uterine cancer	0.000316	0.00069	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—uterine cancer	0.000307	0.00067	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—uterine cancer	0.000304	0.000664	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—uterine cancer	0.000302	0.000658	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—uterine cancer	0.000301	0.000658	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—uterine cancer	0.0003	0.000654	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—uterine cancer	0.000284	0.00062	CcSEcCtD
